MPWT
DAWN

MassMutual Private Wealth & Trust’s Day One Biopharmaceuticals DAWN Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-51
Closed -$332 – 2392
2025
Q2 		$332 Buy
+51
New +$351 ﹤0.01% 2266

Other funds holding DAWN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

MassMutual Private Wealth & Trust's DAWN Position: Q3 2025 in Review

MassMutual Private Wealth & Trust sold out of Day One Biopharmaceuticals (DAWN) in Q3 2025, closing a stake of 51 shares — an estimated $332 sold.

MassMutual Private Wealth & Trust first reported a position in DAWN in Q2 2025 and held it in 1 quarter. The position peaked at $332 in Q2 2025. 172 funds tracked by Wall St. Rank hold DAWN as of Q3 2025.

  • MassMutual Private Wealth & Trust reported no remaining Day One Biopharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 51 Day One Biopharmaceuticals shares in Q3 2025, an estimated $332.
  • MassMutual Private Wealth & Trust first reported a position in Day One Biopharmaceuticals in Q2 2025 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Day One Biopharmaceuticals position peaked at $332 in Q2 2025.
  • 172 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2025, filed 22 Oct 2025.